> top > docs > PubMed:33181156 > annotations

PubMed:33181156 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 551-557 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T2 1094-1100 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T3 1156-1162 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T4 1378-1384 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T5 1471-1476 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T6 1587-1593 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T7 1614-1620 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T8 1874-1880 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T9 2062-2067 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 551-557 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T2 1094-1100 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T3 1156-1162 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T4 1378-1384 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T5 1471-1476 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T6 1587-1593 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T7 1614-1620 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T8 1874-1880 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T9 2062-2067 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 22-24 Disease denotes GN http://purl.obolibrary.org/obo/MONDO_0005033
T2 65-73 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 78-96 Disease denotes glomerular disease http://purl.obolibrary.org/obo/MONDO_0019722
T4 138-146 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T5 149-158 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T6 195-213 Disease denotes glomerulonephritis http://purl.obolibrary.org/obo/MONDO_0002462
T7 341-350 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T8 354-372 Disease denotes glomerulonephritis http://purl.obolibrary.org/obo/MONDO_0002462
T9 379-381 Disease denotes GN http://purl.obolibrary.org/obo/MONDO_0005033
T10 416-434 Disease denotes glomerulonephritis http://purl.obolibrary.org/obo/MONDO_0002462
T11 439-447 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 521-539 Disease denotes glomerulonephritis http://purl.obolibrary.org/obo/MONDO_0002462
T13 610-619 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T14 730-738 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T15 836-854 Disease denotes glomerulonephritis http://purl.obolibrary.org/obo/MONDO_0002462
T16 879-888 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T17 930-948 Disease denotes glomerulonephritis http://purl.obolibrary.org/obo/MONDO_0002462
T18 1003-1021 Disease denotes glomerulonephritis http://purl.obolibrary.org/obo/MONDO_0002462
T19 1088-1107 Disease denotes acute kidney injury http://purl.obolibrary.org/obo/MONDO_0002492
T20 1101-1107 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T21 1372-1391 Disease denotes acute kidney injury http://purl.obolibrary.org/obo/MONDO_0002492
T22 1385-1391 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T23 1399-1417 Disease denotes glomerulonephritis http://purl.obolibrary.org/obo/MONDO_0002462
T24 1445-1463 Disease denotes glomerulonephritis http://purl.obolibrary.org/obo/MONDO_0002462
T25 1525-1543 Disease denotes glomerular disease http://purl.obolibrary.org/obo/MONDO_0019722
T26 1581-1600 Disease denotes acute kidney injury http://purl.obolibrary.org/obo/MONDO_0002492
T27 1594-1600 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T28 1708-1726 Disease denotes glomerulonephritis http://purl.obolibrary.org/obo/MONDO_0002462
T29 1734-1752 Disease denotes glomerulonephritis http://purl.obolibrary.org/obo/MONDO_0002462
T30 1771-1798 Disease denotes systemic autoimmune disease http://purl.obolibrary.org/obo/MONDO_0015939
T31 1780-1798 Disease denotes autoimmune disease http://purl.obolibrary.org/obo/MONDO_0007179
T32 1800-1805 Disease denotes lupus http://purl.obolibrary.org/obo/MONDO_0004670
T33 1809-1819 Disease denotes vasculitis http://purl.obolibrary.org/obo/MONDO_0018882
T34 1868-1887 Disease denotes acute kidney injury http://purl.obolibrary.org/obo/MONDO_0002492
T35 1881-1887 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T36 1927-1945 Disease denotes glomerulonephritis http://purl.obolibrary.org/obo/MONDO_0002462
T37 1961-1979 Disease denotes glomerulonephritis http://purl.obolibrary.org/obo/MONDO_0002462
T38 1984-1992 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 551-557 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T2 551-557 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T3 551-557 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney
T4 1094-1100 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T5 1094-1100 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T6 1094-1100 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney
T7 1156-1162 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T8 1156-1162 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T9 1156-1162 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney
T10 1378-1384 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T11 1378-1384 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T12 1378-1384 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney
T13 1587-1593 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T14 1587-1593 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T15 1587-1593 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney
T16 1614-1620 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T17 1614-1620 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T18 1614-1620 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney
T19 1769-1770 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T20 1874-1880 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T21 1874-1880 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T22 1874-1880 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 22-24 Chemical denotes GN http://purl.obolibrary.org/obo/CHEBI_73888
T2 379-381 Chemical denotes GN http://purl.obolibrary.org/obo/CHEBI_73888
T3 1276-1287 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T4 1288-1299 Chemical denotes aldosterone http://purl.obolibrary.org/obo/CHEBI_27584|http://purl.obolibrary.org/obo/CHEBI_30834
T6 1307-1317 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3 51-59 Species denotes patients Tax:9606
4 65-73 Disease denotes COVID-19 MESH:C000657245
5 78-96 Disease denotes glomerular disease MESH:D007674
44 138-158 Disease denotes SARS-CoV-2 infection MESH:C000657245
45 195-213 Disease denotes glomerulonephritis MESH:D005921
46 335-350 Disease denotes COVID infection MESH:C000657245
47 354-372 Disease denotes glomerulonephritis MESH:D005921
48 402-410 Species denotes patients Tax:9606
49 416-434 Disease denotes glomerulonephritis MESH:D005921
50 439-447 Disease denotes COVID-19 MESH:C000657245
51 521-539 Disease denotes glomerulonephritis MESH:D005921
52 610-619 Disease denotes infection MESH:D007239
53 730-738 Disease denotes COVID-19 MESH:C000657245
54 771-776 Disease denotes COVID MESH:C000657245
55 836-854 Disease denotes glomerulonephritis MESH:D005921
56 879-888 Disease denotes infection MESH:D007239
57 916-924 Species denotes patients Tax:9606
58 930-948 Disease denotes glomerulonephritis MESH:D005921
59 989-997 Species denotes Patients Tax:9606
60 1003-1021 Disease denotes glomerulonephritis MESH:D005921
61 1047-1056 Disease denotes mortality MESH:D003643
62 1088-1107 Disease denotes acute kidney injury MESH:D058186
63 1288-1299 Chemical denotes aldosterone MESH:D000450
64 1363-1368 Disease denotes death MESH:D003643
65 1372-1391 Disease denotes acute kidney injury MESH:D058186
66 1399-1417 Disease denotes glomerulonephritis MESH:D005921
67 1445-1463 Disease denotes glomerulonephritis MESH:D005921
68 1477-1484 Gene denotes albumin Gene:213
69 1525-1543 Disease denotes glomerular disease MESH:D007674
70 1581-1600 Disease denotes acute kidney injury MESH:D058186
71 1686-1694 Species denotes patients Tax:9606
72 1708-1752 Disease denotes glomerulonephritis versus glomerulonephritis MESH:D005921
73 1771-1798 Disease denotes systemic autoimmune disease MESH:D020274
74 1800-1819 Disease denotes lupus or vasculitis MESH:D020945
75 1846-1855 Disease denotes mortality MESH:D003643
76 1868-1887 Disease denotes acute kidney injury MESH:D058186
77 1927-1945 Disease denotes glomerulonephritis MESH:D005921
78 1947-1955 Species denotes patients Tax:9606
79 1961-1979 Disease denotes glomerulonephritis MESH:D005921
80 1984-1992 Disease denotes COVID-19 MESH:C000657245
81 2068-2075 Gene denotes albumin Gene:213

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-122 Sentence denotes Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring.
T2 123-282 Sentence denotes The effects of SARS-CoV-2 infection on individuals with immune-mediated glomerulonephritis, who are often undergoing immunosuppressive treatments, are unknown.
T3 283-496 Sentence denotes Therefore, we created the International Registry of COVID infection in glomerulonephritis (IRoc-GN), and identified 40 patients with glomerulonephritis and COVID-19 followed in centers in North America and Europe.
T4 497-739 Sentence denotes Detailed information on glomerulonephritis diagnosis, kidney parameters, and baseline immunosuppression prior to infection were recorded, as well as clinical presentation, laboratory values, treatment, complications, and outcomes of COVID-19.
T5 740-889 Sentence denotes This cohort was compared to 80 COVID-positive control cases from the general population without glomerulonephritis matched for the time of infection.
T6 890-988 Sentence denotes The majority (70%) of the patients with glomerulonephritis and all the controls were hospitalized.
T7 989-1238 Sentence denotes Patients with glomerulonephritis had significantly higher mortality (15% vs. 5%, respectively) and acute kidney injury (39% vs. 14%) than controls, while the need for kidney replacement therapy was not statistically different between the two groups.
T8 1239-1425 Sentence denotes Receiving immunosuppression or renin-angiotensin-aldosterone system inhibitors at presentation did not increase the risk of death or acute kidney injury in the glomerulonephritis cohort.
T9 1426-1641 Sentence denotes In the cohort with glomerulonephritis, lower serum albumin at presentation and shorter duration of glomerular disease were associated with greater risk of acute kidney injury and need for kidney replacement therapy.
T10 1642-1821 Sentence denotes No differences in outcomes occurred between patients with primary glomerulonephritis versus glomerulonephritis associated with a systemic autoimmune disease (lupus or vasculitis).
T11 1822-2083 Sentence denotes Thus, due to the higher mortality and risk of acute kidney injury than in the general population without glomerulonephritis, patients with glomerulonephritis and COVID-19 should be carefully monitored, especially when they present with low serum albumin levels.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 195-213 Phenotype denotes glomerulonephritis http://purl.obolibrary.org/obo/HP_0000099
T2 354-372 Phenotype denotes glomerulonephritis http://purl.obolibrary.org/obo/HP_0000099
T3 416-434 Phenotype denotes glomerulonephritis http://purl.obolibrary.org/obo/HP_0000099
T4 521-539 Phenotype denotes glomerulonephritis http://purl.obolibrary.org/obo/HP_0000099
T5 836-854 Phenotype denotes glomerulonephritis http://purl.obolibrary.org/obo/HP_0000099
T6 930-948 Phenotype denotes glomerulonephritis http://purl.obolibrary.org/obo/HP_0000099
T7 1003-1021 Phenotype denotes glomerulonephritis http://purl.obolibrary.org/obo/HP_0000099
T8 1088-1107 Phenotype denotes acute kidney injury http://purl.obolibrary.org/obo/HP_0001919
T9 1372-1391 Phenotype denotes acute kidney injury http://purl.obolibrary.org/obo/HP_0001919
T10 1399-1417 Phenotype denotes glomerulonephritis http://purl.obolibrary.org/obo/HP_0000099
T11 1445-1463 Phenotype denotes glomerulonephritis http://purl.obolibrary.org/obo/HP_0000099
T12 1581-1600 Phenotype denotes acute kidney injury http://purl.obolibrary.org/obo/HP_0001919
T13 1708-1726 Phenotype denotes glomerulonephritis http://purl.obolibrary.org/obo/HP_0000099
T14 1734-1752 Phenotype denotes glomerulonephritis http://purl.obolibrary.org/obo/HP_0000099
T15 1780-1798 Phenotype denotes autoimmune disease http://purl.obolibrary.org/obo/HP_0002960
T16 1809-1819 Phenotype denotes vasculitis http://purl.obolibrary.org/obo/HP_0002633
T17 1868-1887 Phenotype denotes acute kidney injury http://purl.obolibrary.org/obo/HP_0001919
T18 1927-1945 Phenotype denotes glomerulonephritis http://purl.obolibrary.org/obo/HP_0000099
T19 1961-1979 Phenotype denotes glomerulonephritis http://purl.obolibrary.org/obo/HP_0000099

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-122 Sentence denotes Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring.
T2 123-282 Sentence denotes The effects of SARS-CoV-2 infection on individuals with immune-mediated glomerulonephritis, who are often undergoing immunosuppressive treatments, are unknown.
T3 283-496 Sentence denotes Therefore, we created the International Registry of COVID infection in glomerulonephritis (IRoc-GN), and identified 40 patients with glomerulonephritis and COVID-19 followed in centers in North America and Europe.
T4 497-739 Sentence denotes Detailed information on glomerulonephritis diagnosis, kidney parameters, and baseline immunosuppression prior to infection were recorded, as well as clinical presentation, laboratory values, treatment, complications, and outcomes of COVID-19.
T5 740-889 Sentence denotes This cohort was compared to 80 COVID-positive control cases from the general population without glomerulonephritis matched for the time of infection.
T6 890-988 Sentence denotes The majority (70%) of the patients with glomerulonephritis and all the controls were hospitalized.
T7 989-1238 Sentence denotes Patients with glomerulonephritis had significantly higher mortality (15% vs. 5%, respectively) and acute kidney injury (39% vs. 14%) than controls, while the need for kidney replacement therapy was not statistically different between the two groups.
T8 1239-1425 Sentence denotes Receiving immunosuppression or renin-angiotensin-aldosterone system inhibitors at presentation did not increase the risk of death or acute kidney injury in the glomerulonephritis cohort.
T9 1426-1641 Sentence denotes In the cohort with glomerulonephritis, lower serum albumin at presentation and shorter duration of glomerular disease were associated with greater risk of acute kidney injury and need for kidney replacement therapy.
T10 1642-1821 Sentence denotes No differences in outcomes occurred between patients with primary glomerulonephritis versus glomerulonephritis associated with a systemic autoimmune disease (lupus or vasculitis).
T11 1822-2083 Sentence denotes Thus, due to the higher mortality and risk of acute kidney injury than in the general population without glomerulonephritis, patients with glomerulonephritis and COVID-19 should be carefully monitored, especially when they present with low serum albumin levels.
T1 0-122 Sentence denotes Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring.
T2 123-282 Sentence denotes The effects of SARS-CoV-2 infection on individuals with immune-mediated glomerulonephritis, who are often undergoing immunosuppressive treatments, are unknown.
T3 283-496 Sentence denotes Therefore, we created the International Registry of COVID infection in glomerulonephritis (IRoc-GN), and identified 40 patients with glomerulonephritis and COVID-19 followed in centers in North America and Europe.
T4 497-739 Sentence denotes Detailed information on glomerulonephritis diagnosis, kidney parameters, and baseline immunosuppression prior to infection were recorded, as well as clinical presentation, laboratory values, treatment, complications, and outcomes of COVID-19.
T5 740-889 Sentence denotes This cohort was compared to 80 COVID-positive control cases from the general population without glomerulonephritis matched for the time of infection.
T6 890-988 Sentence denotes The majority (70%) of the patients with glomerulonephritis and all the controls were hospitalized.
T7 989-1238 Sentence denotes Patients with glomerulonephritis had significantly higher mortality (15% vs. 5%, respectively) and acute kidney injury (39% vs. 14%) than controls, while the need for kidney replacement therapy was not statistically different between the two groups.
T8 1239-1425 Sentence denotes Receiving immunosuppression or renin-angiotensin-aldosterone system inhibitors at presentation did not increase the risk of death or acute kidney injury in the glomerulonephritis cohort.
T9 1426-1641 Sentence denotes In the cohort with glomerulonephritis, lower serum albumin at presentation and shorter duration of glomerular disease were associated with greater risk of acute kidney injury and need for kidney replacement therapy.
T10 1642-1821 Sentence denotes No differences in outcomes occurred between patients with primary glomerulonephritis versus glomerulonephritis associated with a systemic autoimmune disease (lupus or vasculitis).
T11 1822-2083 Sentence denotes Thus, due to the higher mortality and risk of acute kidney injury than in the general population without glomerulonephritis, patients with glomerulonephritis and COVID-19 should be carefully monitored, especially when they present with low serum albumin levels.